[NBY] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 87.57%
YoY- 92.69%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 3,643 3,826 3,045 2,629 2,641 1,840 2,133 42.74%
PBT -8,206 -136 -2,155 -111 -158 -2,289 -1,859 168.36%
Tax -3,488 -321 3 -2,271 735 -1 300 -
NP -8,206 -5,793 -2,155 -111 -893 -2,289 -1,859 168.36%
Tax Rate - - - - - - - -
Total Cost 11,849 9,619 5,200 2,740 3,534 4,129 3,992 106.12%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -225.25 -151.41 -70.77 -4.22 -33.81 -124.40 -87.15 88.00%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -4.33 -3.61 -1.43 -0.08 -0.69 -1.78 -1.53 99.69%
EPS Diluted -4.33 -3.61 -1.43 -0.08 -0.69 -1.78 -1.53 99.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.